- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06802783
Impact of Procedure Materials on Patient Anxiety, Depression, and Pain in Prostate Biopsy Consent
January 26, 2025 updated by: Marmara University
The gold standard for diagnosing prostate cancer is an ultrasound-guided prostate biopsy.
Despite its low complication rates, the procedure can cause significant stress, discomfort and anxiety in patients.
This study aimed to determine whether visually introducing the materials (ultrasound, probe, biopsy needle) used during the biopsy could reduce patient anxiety and increase comfort.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Forty patients suspected of having prostate cancer were included in this prospective study.
All patients received detailed information about the procedure, but they were divided into two groups.
The first group was shown photographs of the devices alongside the written consent form, while the second group received only the written consent.
The study compared the pain, depression and anxiety scores between the two groups
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34854
- Marmara University School of Medicine Urology Department
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- patient's clinical data indicated the need for a prostate biopsy
Exclusion Criteria:
- included having a diagnosis of psychiatric illness
- having previously undergone a prostate biopsy under local anesthesia
- being a patient under active surveillance for prostate cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: written consent group
Only traditional written consent will be provided to this group.
|
|
|
Active Comparator: photo-consent group
Photo consent which show materials use in procedure will be provided to this group before the biopsy
|
The first group was shown photographs of the devices alongside the written consent form, while the second group received only the written consent.
The study compared the pain, depression and anxiety scores between the two groups.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety Level
Time Frame: Pre-procedure
|
For Anxiety, Hospital Anxiety Scale used.
In the Hospital Anxiety Score, the minimum score is 0, and the maximum score is 21.
As the score increases, it indicates higher levels of anxiety.
|
Pre-procedure
|
|
Depression Level
Time Frame: Pre-procedure
|
For Depression, Hospital Depression Scale used .
In the Hospital Depression Score, the minimum score is 0, and the maximum score is 21.
As the score increases, it indicates higher levels of depression.
|
Pre-procedure
|
|
Pain Level
Time Frame: Pre procedure
|
For Pain, Visual Analog Scale used.
In the Visual Analog Pain Scale, the minimum score is 0, and the maximum score is 10.
As the score increases, it indicates higher levels of pain.
|
Pre procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety Level
Time Frame: Immediately after the procedure
|
For Anxiety, Hospital Anxiety Scale used.
In the Hospital Anxiety Score, the minimum score is 0, and the maximum score is 21.
As the score increases, it indicates higher levels of anxiety.
|
Immediately after the procedure
|
|
Depression Level
Time Frame: Immediately after the procedure
|
For Depression, Hospital Depression Scale used .
In the Hospital Depression Score, the minimum score is 0, and the maximum score is 21.
As the score increases, it indicates higher levels of depression
|
Immediately after the procedure
|
|
Pain Level
Time Frame: Immediately after the procedure
|
For Pain, Visual Analog Scale used.
In the Visual Analog Pain Scale, the minimum score is 0, and the maximum score is 10.
As the score increases, it indicates higher levels of pain.
|
Immediately after the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: BAHADIR SAHIN, MARMARA UNİVERSİTY SCHOOL OF MEDİCİNE DEPARTMENT OF UROLOGY
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2024
Primary Completion (Actual)
November 12, 2024
Study Completion (Estimated)
January 30, 2025
Study Registration Dates
First Submitted
December 23, 2024
First Submitted That Met QC Criteria
January 26, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 26, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MAR.UAD.0017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Biopsy
-
Veterans Health Service Medical Center, Seoul,...RecruitingProstate Biopsy | Post Biopsy Bleeding | Transrectal Ultrasound-guided Prostate BiopsySouth Korea
-
Shanghai East HospitalNot yet recruiting
-
Mayo ClinicClear Guide Medical Inc.Enrolling by invitation
-
Royal Marsden NHS Foundation TrustCompleted
-
Modarres HospitalCompleted
-
The University of Texas Health Science Center at...CompletedProstate Biopsy | Antibiotic TherapyUnited States
-
Rijnstate HospitalWithdrawn
-
University Hospital, GrenobleNot yet recruiting
-
Hospital General Universitario Gregorio MarañonRecruitingEvaluate Requirements of 2% Prilocaine in MR-UF Prostate BiopsySpain
-
Tarsus UniversityMersin UniversityCompleted
Clinical Trials on Photo consent
-
Columbia UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedMedical Errors | Electronic Medical RecordsUnited States
-
Mansoura UniversityCompletedPreterm Infants
-
Nantes University HospitalRecruiting
-
West China HospitalRecruiting
-
Johns Hopkins Bloomberg School of Public HealthVital StrategiesCompletedOpioid Use Disorder | Substance Use Disorders | Stigma, SocialUnited States
-
Washington University School of MedicineUniversity of PennsylvaniaCompletedAlzheimer DiseaseUnited States
-
Temple UniversityNational Institute of Nursing Research (NINR)RecruitingViolence and VictimizationUnited States
-
National Taiwan University HospitalUniversity of BonnRecruiting
-
Universidad de ExtremaduraRecruiting
-
Harvard UniversityCompleted